Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease

被引:26
|
作者
Bi, Christopher [1 ]
Bi, Stephanie [1 ]
Li, Bin [1 ,2 ]
机构
[1] Washington Inst Hlth Sci, Arlington, VA 22203 USA
[2] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Med Ctr, 3900 Reservoir Rd, Washington, DC 20057 USA
来源
AGING AND DISEASE | 2019年 / 10卷 / 02期
关键词
Alzheimer's disease; APP mutation; APP processing; clinico-pathological features; cellular models; animal models; HEREDITARY CEREBRAL-HEMORRHAGE; C-TERMINAL FRAGMENT; ENDOPLASMIC-RETICULUM STRESS; A-BETA; TRANSGENIC MICE; APP GENE; MOUSE MODEL; MISSENSE MUTATION; COGNITIVE IMPAIRMENT; AUTOSOMAL-DOMINANT;
D O I
10.14336/AD.2018.0425
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is a complex, multifactorial disease involving many pathological mechanisms. Nonetheless, single pathogenic mutations in amyloid precursor protein (APP) or presenilin 1 or 2 can cause AD with almost all of the clinical and neuropathological features, and therefore, we believe an important mechanism of pathogenesis in AD could be revealed from examining pathogenic APP missense mutations. A comprehensive review of the literature, including clinical, neuropathological, cellular and animal model data, was conducted through PubMed and the databases of Alzforum mutations, HGMD, UniProt, and AD&FTDMDB. Pearson correlation analysis combining the clinical and neuropathological data and aspects of mutant APP processing in cellular models was performed. We find that an increase in A beta 42 has a significant positive correlation with the appearance of neurofibrillary tangles (NFTs) and tends to cause an earlier age of AD onset, while an increase in A beta 40 significantly increases the age at death. The increase in the alpha-carboxyl terminal fragment (CTF) has a significantly negative correlation with the age of AD onset, and beta-CTF has a similar effect without statistical significance. Animal models show that intracellular A beta is critical for memory defects. Based on these results and the fact that amyloid plaque burden correlates much less well with cognitive impairment than do NFT counts, we propose a "snowball hypothesis": the accumulation of intraneuronal NFTs caused by extracellular A beta 42 and the increase in intraneuronal APP proteolytic products (CTFs and A beta s) could cause cellular organelle stress that leads to neurodegeneration in AD, which then resembles the formation of abnormal protein "snowballs" both inside and outside of neurons.
引用
收藏
页码:383 / 403
页数:21
相关论文
共 50 条
  • [31] Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease
    R. Michael Dutescu
    Qiao-Xin Li
    Jonathan Crowston
    Colin L. Masters
    Paul N. Baird
    Janetta G. Culvenor
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1213 - 1221
  • [32] Modulation of amyloid β protein precursor processing as a means of retarding progression of Alzheimer's disease
    Wagner, SL
    Munoz, B
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10): : 1329 - 1332
  • [33] Processing of the Alzheimer's Disease beta A4 Amyloid Protein Precursor (APP)
    Younkin, Steven G.
    BRAIN PATHOLOGY, 1991, 1 (04) : 253 - 262
  • [34] TDP-43 and amyloid precursor protein processing: implications for Alzheimer's disease
    David A.Hicks
    Neural Regeneration Research, 2021, 16 (07) : 1402 - 1403
  • [35] The effect of simvastatin treatment the processing of the amyloid precursor protein in patients with Alzheimer's disease
    Hoglund, K
    Thelen, KM
    Syversen, S
    Sjogren, M
    von Bergmann, K
    Wallin, A
    Vanmechelen, E
    Vanderstichele, H
    Luetjohann, D
    Blennow, K
    NEUROBIOLOGY OF AGING, 2004, 25 : S584 - S584
  • [36] Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease
    Ling, Y
    Morgan, K
    Kalsheker, N
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (11): : 1505 - 1535
  • [37] Vasopressin and Bradykinin Regulate Secretory Processing of the Amyloid Protein Precursor of Alzheimer's Disease
    Roger M. Nitsch
    Cindy Kim
    John H. Growdon
    Neurochemical Research, 1998, 23 : 807 - 814
  • [38] Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease
    Nitsch, RM
    Kim, C
    Growdon, JH
    NEUROCHEMICAL RESEARCH, 1998, 23 (05) : 807 - 814
  • [39] The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease
    Tan, Jing Zhi A.
    Gleeson, Paul A.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2019, 1861 (04): : 697 - 712
  • [40] Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
    Ben Halima, Saoussen
    Mishra, Sabyashachi
    Raja, K. Muruga Poopathi
    Willem, Michael
    Baici, Antonio
    Simons, Kai
    Bruestle, Oliver
    Koch, Philipp
    Haass, Christian
    Caflisch, Amedeo
    Rajendran, Lawrence
    CELL REPORTS, 2016, 14 (09): : 2127 - 2141